ReviewBiodesign research2026
Prime editing: Emerging mechanisms, engineering innovations, and next-generation applications.
Review in Biodesign research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prime editing has become a highly programmable and accurate genome-editing platform that can install targeted substitutions, insertions, and deletions without introducing double-strand breaks or requiring a separate donor DNA template. This review summarizes recent developments about prime editing mechanisms, such as knowledge about flap dynamics, repair pathway interactions, and pegRNA architecture, and improvements in engineering, resulting in high-efficiency systems, including PEmax, PE4/5, TWIN-PE, PASTE, and PrimeRoot. Such advances now make prime editing applicable to therapeutic gene correction, agricultural biotechnology, microbial engineering, and functional genomics. However, delivery, chromatin context, mismatch-repair variability, and large-fragment integration remain major barriers to broad application. By comparing prime editing with other genome-editing modalities, this review summarizes its unique advantages and highlights strategic innovations needed for its next stage of development. Together, these developments position prime editing as a highly programmable platform with strong potential to shape the future of precise genome rewriting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.